About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

36.00 +0.34 (+0.95%)
Streaming Delayed Price Updated: 2:04 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

News headline image
Down 80%, Should You Buy the Dip on Moderna? ↗
Your decision on whether to invest now depends to some extent on your investment strategy. 
Via The Motley Fool
News headline image
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
News headline image
Why Moderna (MRNA) Stock Is Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would receive up to $54.3 million in funding from the Coalition for Epidemic... 
Via StockStory
Topics Artificial Intelligence
News headline image
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
Via ACCESS Newswire
News headline image
Moderna (MRNA) Stock Trades Up, Here Is Why
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the afternoon session after the broader biotech sector experienced a strong rebound, lifting shares of companies within the industry. 
Via StockStory
Topics Artificial Intelligence
News headline image
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
Via ACCESS Newswire
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
New York, NY – December 16, 2025 – Pfizer Inc. (NYSE: PFE) today delivered a sobering financial outlook for 2026, projecting revenue and adjusted earnings per share (EPS) that fell short of Wall... 
Via MarketMinute
Topics Intellectual Property
News headline image
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
Via ACCESS Newswire
News headline image
3 Cash-Burning Stocks We Steer Clear Of
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable. 
Via StockStory
News headline image
Moderna (MRNA) Q4 2024 Earnings Call Transcript ↗
Moderna (MRNA) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q3 2024 Earnings Call Transcript ↗
Moderna (MRNA) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q1 2025 Earnings Call Transcript ↗
Moderna (MRNA) Q1 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Moderna (MRNA) Q2 2025 Earnings Call Transcript ↗
Moderna (MRNA) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Moderna (MRNA) Q3 2025 Earnings Call Transcript ↗
Moderna (MRNA) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? ↗
Investors remain divided on Moderna and Super Micro as heavy short interest reflects skepticism, yet recent catalysts suggest both names could still deliver unpredictable, sentiment-driven swings. 
Via Stocktwits
Topics Artificial Intelligence Stocks
News headline image
Growth Stocks Maintain Dominance in S&P 500 Amidst AI Enthusiasm, Sparking Market Concentration Concerns
New York, NY – December 9, 2025 – Growth stocks within the S&P 500 have continued their remarkable ascent, significantly outpacing their value counterparts throughout 2025. This enduring trend, largely... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Invisible Hand of Emotion: How Investor Psychology Shapes 2025's Stock Market Trajectory
In the intricate dance of global finance, where algorithms whir and economic data points are meticulously dissected, an often-overlooked yet profoundly powerful force consistently asserts its... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Global AI Infrastructure Shift Ignites Biotech Growth Phase
From USA News Group
Via GlobeNewswire
News headline image
Friday's session: top gainers and losers in the S&P500 index ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective. 
Via StockStory
Topics Economy
News headline image
These S&P500 stocks are moving in today's session ↗
Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
What's Going On With Moderna Stock Monday? ↗
Shares of Moderna, Inc. (NASDAQ:MRNA) are trading lower Monday following reports suggesting tighter controls on how vaccines gain approval. 
Via Benzinga
News headline image
Discover which S&P500 stocks are making waves on Monday. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Gapping S&P500 stocks in Monday's session ↗
Curious about the S&P500 stocks that are gapping on Monday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children. 
Via Investor's Business Daily
Topics Death
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Curious about the S&P500 stocks that are showing activity before the opening bell on Monday? 
Via Chartmill
News headline image
Top S&P500 movers in Friday's session ↗
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Where Will Vertex Pharmaceuticals Be in 5 Years ↗
Prediction: Vertex will be much larger by the end of the decade. 
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.